期刊文献+

恶性肿瘤血栓并发症86例临床分析 被引量:6

恶性肿瘤血栓并发症86例临床分析
在线阅读 下载PDF
导出
摘要 目的探讨恶性肿瘤患者血栓并发症形成的原因、治疗策略及对生存的影响。方法选择我院2007年~2010年已确诊恶性肿瘤并发血栓性疾病患者86例,随机分为对照组和治疗组各43例,对治疗组进行相应的抗凝治疗和溶栓治疗。结果恶性肿瘤患者最易形成深静脉血栓(DVT),治疗组的治疗有效率为76.74%,而对照组为51.16%,两组差异有显著性差异(P<0.05);随访发现治疗组生存率较对照组为低。结论恶性肿瘤并发血栓性疾病患者预后较差;正确诊断,积极治疗,能明显地改善患者的预后和整体生活质量。 Objective To study the formation of thrombotic complications in patients with malignant causes, treatment and impact on survival. Methods Choice in our hospital have been diagnosed in 2007~2010 Malignancies 86 patients with thrombotic disease, patients were randomly divided into control group and treatment group 43 cases, corresponding to the treatment group anticoagulant therapy and thrombolytic therapy. Results The results are most vulnerable to the formation of cancer patients with deep vein thrombosis (DVT), treatment group, the treatment rate was 76.74 percent, while the control group was only 51.16%, a significant statistical difference (P〈0.05); follow up, treatment group, survival rate lower than the control group. Conclusion Malignancies poor prognosis of patients with thrombotic disease; correct diagnosis, active treatment, can significantly improve the prognosis of patients and the overall quality of life.
作者 曾福仁
出处 《当代医学》 2010年第19期15-16,共2页 Contemporary Medicine
关键词 恶性肿瘤 血栓性疾病 原因 malignant thrombotic disease
  • 相关文献

参考文献7

二级参考文献38

  • 1Dell D D.Deep vein thrombosis in the patient with cancer[J].Clin J Oncol Nurs,2002,6(1):43-46.
  • 2Sutherland D E,Weitz I C,Liebman H A.Thromboembolic complications of cancer:epidemiology,pathogenesis,diagnosis,and treatment[J].Am J Hematol,2003,72(1):43-52.
  • 3Luxembourg B,Bauersachs R.Malignancy and thrombosis:a double-sided clinical relationship[J].Vasa,2005,34 (4):225 -234.
  • 4Baron J A,Gridley G,Weiderpass E,et al.Venous thromboem bolism and cancer[J].Lancet,1998,351 (9109):1077-1080.
  • 5Thodiyil P A,Kakkar A K.Variation in relative risk of venous thromboembolism in different cancers[J].Thromb Haemost,2002,87(6):1076-1077.
  • 6Rosovsky R P,Kuter D J.Catheter-related thrombosis in cancer patients:pathophysiology,diagnosis,and management[J].Hematol Oncol Clin North Am,2005,19(1):183-202.
  • 7Falanga A,Tickles F R.Pathophysiology of the thrombophilic state in the cancer patient[J].Semin Thromb Hemost,1999,25(2):173-182.
  • 8Shoji M,Hancock W W,Abe K,et al.Activation of coagulation and angiogenesis in cancer:immunohistochemical localization in situ of clotting proteins and vascu-lar endothelial growth factor in humancancer[J].AmJPathol,1998,152(2):399-411.
  • 9Bromberg M E,Cappello M.Cancer and blood coagulation:molecular aspects[J].Cancer J Sci Am,1999,5(3):132-138.
  • 10Kakkar A K.Low molecular-weight heparins:beyond thrombosis in the management of the cancer patient[J].Semin Thromb Hemost,2003,29(Suppl 1):13-15.

共引文献99

同被引文献53

引证文献6

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部